Cargando…

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody

Anti-NXP2 antibodies should be tested in patients with dermatomyositis, ILD and idiopathic inflammatory myopathies http://ow.ly/KiEMe

Detalles Bibliográficos
Autores principales:	Gossez, Morgane, Levesque, Marianne, Khouatra, Chahéra, Cottin, Vincent, Garnier, Lorna, Fabien, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2015
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487820/ https://www.ncbi.nlm.nih.gov/pubmed/26028648 http://dx.doi.org/10.1183/16000617.00006714

Ejemplares similares

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
por: Ceribelli, Angela, et al.
Publicado: (2012)

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
por: Tansley, Sarah L., et al.
Publicado: (2014)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
por: Toplak, Natasa, et al.
Publicado: (2022)

A rare case of NXP-2 positive dermatomyositis
por: Khan, Nariman, et al.
Publicado: (2021)

A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer
por: Fushida, Natsumi, et al.
Publicado: (2021)

NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation
por: Butt, Zeeshan, et al.
Publicado: (2017)

A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies
por: Ito, Mitsuru, et al.
Publicado: (2020)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
por: Butt, Zeeshan, et al.
Publicado: (2018)

Clinical Images: Degos‐like lesions in association with NXP‐2 dermatomyositis
por: Alhassan, Eaman, et al.
Publicado: (2023)

Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis
por: Grobost, Vincent, et al.
Publicado: (2014)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Rapidly progressive interstitial pneumonia associated with anti-NXP2 antibody secondary to malignancy
por: Wuthithepbuncha, Nataphon, et al.
Publicado: (2022)

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature
por: Xu, Yingjie, et al.
Publicado: (2021)

Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups
por: Chebib, Nader, et al.
Publicado: (2018)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
por: Kishi, Takayuki, et al.
Publicado: (2021)

Spontaneous pneumomediastinum and cutaneous ulcers complicated in a patient with dermatomyositis and interstitial lung disease
por: Kwon, Mihye
Publicado: (2021)

An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations
por: Fredi, Micaela, et al.
Publicado: (2022)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey
por: Jardel, Sabine, et al.
Publicado: (2017)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
por: Sclafani, A., et al.
Publicado: (2019)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children
por: Wang, Xinning, et al.
Publicado: (2021)

Dermatomyosite à anticorps anti-NXP2 et COVID-19 : comorbidité ou complication ?
por: Hecham, Nassima, et al.
Publicado: (2023)

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019)

Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Tozinameran: Dermatomyositis complicated by interstitial lung disease: case report
Publicado: (2022)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum
por: Marasandra Ramesh, Harshita, et al.
Publicado: (2022)

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
por: Nicolas, Philippe, et al.
Publicado: (2022)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

2. Two cases of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease
por: Levasseur, Kirsty, et al.
Publicado: (2019)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
por: Aissaoui, Houari, et al.
Publicado: (2021)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

Right-to-left shunt with hypoxemia in pulmonary hypertension
por: Vodoz, Jean-Frédéric, et al.
Publicado: (2009)

Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
por: Li, Liubing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oacn5kf3nng0b3q30pktec4e40